Loading...
Fresenius Medical Care AG & Co. KGaA
FMCQF•PNK
HealthcareMedical - Care Facilities
$58.68
$0.00(0.00%)
Fresenius Medical Care AG & Co. KGaA (FMCQF) Financial Performance & Statements
Review Fresenius Medical Care AG & Co. KGaA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.61%
↓ 0.61%
Operating Income Growth
1.68%
↑ 1.68%
Net Income Growth
7.80%
↑ 7.80%
Operating Cash Flow Growth
-9.23%
↓ 9.23%
Operating Margin
7.21%
↑ 7.21%
Gross Margin
24.46%
↑ 24.46%
Net Profit Margin
3.17%
↑ 3.17%
ROE
4.38%
↑ 4.38%
ROIC
5.15%
↑ 5.15%
Fresenius Medical Care AG & Co. KGaA (FMCQF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Fresenius Medical Care AG & Co. KGaA stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.08B | $4.76B | $4.77B | $4.72B |
| Cost of Revenue | $3.81B | $3.61B | $3.60B | $3.55B |
| Gross Profit | $1.27B | $1.15B | $1.17B | $1.17B |
| Gross Profit Ratio | $0.25 | $0.24 | $0.24 | $0.25 |
| R&D Expenses | $50.49M | $40.00M | $45.59M | $47.80M |
| SG&A Expenses | $839.82M | $756.15M | $768.21M | $650.94M |
| Operating Expenses | $1.01B | $684.00M | $813.79M | $698.74M |
| Total Costs & Expenses | $4.83B | $4.30B | $4.41B | $4.51B |
| Interest Income | $21.57M | $17.00M | $18.00M | $15.66M |
| Interest Expense | $101.04M | $99.00M | $103.00M | $103.85M |
| Depreciation & Amortization | $0.00 | $365.00M | $383.76M | $387.74M |
| EBITDA | $280.97M | $804.00M | $793.66M | $620.57M |
| EBITDA Ratio | $0.06 | $0.17 | $0.17 | $0.13 |
| Operating Income | $259.39M | $462.00M | $352.69M | $474.91M |
| Operating Income Ratio | $0.05 | $0.10 | $0.07 | $0.10 |
| Other Income/Expenses (Net) | -$112.39M | -$122.00M | -$118.18M | -$88.00M |
| Income Before Tax | $147.00M | $340.00M | $306.82M | $129.00M |
| Income Before Tax Ratio | $0.03 | $0.07 | $0.06 | $0.03 |
| Income Tax Expense | $61.06M | $116.00M | $99.01M | $40.00M |
| Net Income | $66.91M | $213.03M | $187.00M | $70.96M |
| Net Income Ratio | $0.01 | $0.04 | $0.04 | $0.02 |
| EPS | $0.23 | $0.73 | $0.64 | $0.24 |
| Diluted EPS | $0.23 | $0.73 | $0.64 | $0.24 |
| Weighted Avg Shares Outstanding | $293.41M | $293.41M | $293.41M | $293.41M |
| Weighted Avg Shares Outstanding (Diluted) | $293.41M | $293.41M | $293.41M | $293.41M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan